oleclumab
conatumumab
panitumumab
mapatumumab
drozitumab
patritumab
duligotuzumab
inotuzumab
naptumomab estafenatox
onartuzumab
lintuzumab
dacetuzumab
lexatumumab
matuzumab
tenatumomab
tigatuzumab
inotuzumab ozogamicin
figitumumab
dalotuzumab
pamrevlumab
nofetumomab
sibrotuzumab
adecatumumab
acrixolimab
avelumab
lucatumumab
pritumumab
iratumumab
teprotumumab
apolizumab
cixutumumab
ramucirumab
volociximab
durvalumab
agonistic monoclonal antibody
cergutuzumab
carlumab
ocrelizumab
sonepcizumab
elotuzumab
samalizumab
tucotuzumab
cantuzumab
oportuzumab monatox
glembatumumab
intetumumab
alacizumab
bivatuzumab
ipilimumab
zalutumumab